• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对患有既往存在或并存神经精神疾病的个体进行慢性丙型肝炎的治疗。

Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease.

作者信息

Van Thiel D H, Friedlander L, De Maria N, Molloy P J, Kania R J, Colantoni A

机构信息

Department of Medicine, University of Kentucky School of Medicine, Lexington 40536, USA.

出版信息

Hepatogastroenterology. 1998 Mar-Apr;45(20):328-30.

PMID:9638401
Abstract

The problems associated with the recognition and management of chronic hepatitis C in a population of individuals with confounding psychiatric disease are identified. The experience of treating such patients and the psychotropic medication required during treatment are reviewed.

摘要

确定了在患有复杂精神疾病的人群中识别和管理慢性丙型肝炎相关的问题。回顾了治疗此类患者的经验以及治疗期间所需的精神药物。

相似文献

1
Treatment of chronic hepatitis C in individuals with pre-existing or confounding neuropsychiatric disease.对患有既往存在或并存神经精神疾病的个体进行慢性丙型肝炎的治疗。
Hepatogastroenterology. 1998 Mar-Apr;45(20):328-30.
2
[Coinfection by human immunodeficiency virus and hepatitis C virus].[人类免疫缺陷病毒与丙型肝炎病毒合并感染]
Rev Clin Esp. 1998 Apr;198(4):237-41.
3
Psychological screening before interferon therapy.干扰素治疗前的心理筛查。
Hepatology. 2001 Feb;33(2):480. doi: 10.1002/hep.510330225.
4
Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.丙型肝炎患者干扰素治疗期间的自身免疫表现:肝病专家的观点。
Minerva Gastroenterol Dietol. 2005 Mar;51(1):55-61.
5
Treatment of chronic hepatitis C in active drug users.活跃吸毒者慢性丙型肝炎的治疗。
N Engl J Med. 2001 Jul 19;345(3):215-7. doi: 10.1056/NEJM200107193450312.
6
An emerging epidemic. Chronic hepatitis C in children.一种新出现的流行病。儿童慢性丙型肝炎。
Adv Nurse Pract. 1999 Oct;7(10):42-6; quiz 47-8.
7
Depression in chronic hepatitis: the virus, the drug, or the ethnic background?
Liver Int. 2008 Apr;28(4):429-31. doi: 10.1111/j.1478-3231.2008.01703.x.
8
Treating hepatitis C: the state of the art.
Gastroenterol Clin North Am. 2004 Mar;33(1 Suppl):S1-9. doi: 10.1016/j.gtc.2003.12.006.
9
Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals.HIV感染个体中慢性丙型肝炎病毒感染的管理与治疗
J HIV Ther. 2007 Mar;12(1):11-7.
10
[Predictive value of diverse viral factors in the response to treatment with interferon in patients with chronic hepatitis C].[多种病毒因素对慢性丙型肝炎患者干扰素治疗反应的预测价值]
Gastroenterol Hepatol. 1998 Oct;21(8):404-12.

引用本文的文献

1
In vitro and in vivo antiviral activity and resistance profile of the hepatitis C virus NS3/4A protease inhibitor ABT-450.丙型肝炎病毒NS3/4A蛋白酶抑制剂ABT-450的体外和体内抗病毒活性及耐药性概况
Antimicrob Agents Chemother. 2015 Feb;59(2):988-97. doi: 10.1128/AAC.04227-14. Epub 2014 Dec 1.
2
Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C).与慢性丙型肝炎(CH-C)患者抑郁相关的基因表达谱。
Brain Behav. 2012 Sep;2(5):525-31. doi: 10.1002/brb3.72. Epub 2012 Jul 6.
3
Hepatitis B and C among veterans on a psychiatric ward.
Dig Dis Sci. 2008 Jun;53(6):1693-8. doi: 10.1007/s10620-007-0045-5.
4
Validation of the FACT-BRM with interferon-alpha treated melanoma patients.
Qual Life Res. 2005 Feb;14(1):133-9. doi: 10.1007/s11136-004-1694-x.
5
Neuropsychiatric adverse effects of interferon-alpha: recognition and management.α-干扰素的神经精神不良反应:识别与处理
CNS Drugs. 2005;19(2):105-23. doi: 10.2165/00023210-200519020-00002.
6
Injection drug use and the hepatitis C virus: considerations for a targeted treatment approach--the case study of Canada.注射吸毒与丙型肝炎病毒:靶向治疗方法的考量——以加拿大为例
J Urban Health. 2004 Sep;81(3):428-47. doi: 10.1093/jurban/jth128.
7
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?不给非法药物使用者治疗丙型肝炎是否合理?
N Engl J Med. 2001 Jul 19;345(3):211-5. doi: 10.1056/NEJM200107193450311.